Health Condition 1: L400- Psoriasis vulgaris
Conditions
Interventions
Intervention1: Individualized Homeopathic
Medicines (IHMs) in lower
potencies (6CH or 12CH) of
centesimal scale: Intervention is planned as administering the indicated homeopathic medicine in desired
Sponsors
Nehru Homoeopathic Medical College & Hospital, Govt. of NCT of Delh
D N De Homoeopathic Medical College Hospital Govt of West Bengal
Dr B R Sur Homoeopathic Medical College Hospital and Research Centre Govt of NCT of Delhi
Eligibility
Inclusion criteria
Inclusion criteria: 1.Cases suffering from psoriasis vulgaris (ICD-10-CM diagnosis code L40.0) mainly affects mainly trunk and the extensor surfaces of the limbs and scalp for at least 3 months 2.Psoriasis of mild (PASI 3.Had not taken any treatment for the past 2 weeks 4.Those aged between 18 and 65 years 5.Participants of either sex 6.Literate patients who can read English, Hindi and/or Bengali. Illiterate participants will be interviewed by the investigators maintaining adequate privacy
Exclusion criteria
Exclusion criteria: 1.Suffering from severe psoriasis (PASI > 15, independent of DLQI score) 2.Suffering from guttate, pustular, erythrodermic and annular varieties of psoriasis 3.Similar looking skin conditions â?? atopic and contact dermatitis, lichen planus, secondary syphilis, mycosis fungoides, tinea corporis, pityriasis rosea, etc. 4.Vulnerable population â?? unconscious, non-ambulatory, too sick for consultation, differently abled, terminally or critically ill subjects. 5.Diagnosed cases of unstable mental or psychiatric illness or other uncontrolled or life-threatening illness affecting quality of life or any organ failure 6.Pregnant and puerperal women, lactating mothers 7.Tobacco chewing and/or smoking, alcoholism, and/or any other form(s) of substance abuse and/or dependence 8.Self-reported immune-compromised state (e.g., HIV) 9.Undergoing homeopathic treatment for any chronic disease(s) within last 6 months 10.Simultaneous participation in any other clinical trial
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Psoriasis area & severity index (PASI)Timepoint: Baseline, every month, up to 6 months | — |
Secondary
| Measure | Time frame |
|---|---|
| Dermatology life quality index (DLQI)Timepoint: Baseline, every month, up to 6 months;Psoriasis Disability Index (PDI)Timepoint: Baseline, every month, up to 6 months | — |
Countries
India
Contacts
Public ContactSubhranil Saha
D N De Homoeopathic Medical College Hospital
Outcome results
None listed